Article debunks claims that gene editing will revolutionise crop breeding in Africa
By Claire Robinson,
GMWatch
| 01. 24. 2023
Gene editing has captured the imagination of academics and professionals working on agricultural development in Africa. They claim the technology has the potential to revolutionise crop breeding, based on assertions of precision, cheapness and speed.
However, these claims are strongly challenged in a new peer-reviewed article by an international group of development experts led by Joeva Sean Rock, Professor of Development Studies at the University of Cambridge, UK. The authors review the evidence and experience of older-style GM crops in Africa, as well as the research findings to date on gene editing. They conclude that unless hard lessons are learned from experience with first-generation GM crops, gene editing projects "are in danger of repeating mistakes of the past".
The article is open access and written in an easy-to-understand style, and we recommend reading it in full.
We've heard it before
The authors find that the narratives around gene editing closely echo the earlier ones underpinning the introduction of older-style GM crops into Africa: "But the reality of GM crops in Africa has not lived up to the hype". Problems include...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...